Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
NCT04970212
·
clinicaltrials.gov ↗
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Hepatocellular
Metastatic Liver Cancer
Interventions
DEVICE:
BioTraceIO Lite
Sponsor
Techsomed Medical Technologies LTD